The same technology that can write poetry, design proteins, or diagnose disease is now being used to prevent something far darker — AI-assisted biological attacks. To get ahead of that threat, OpenAI has teamed up with Founders Fund and Lux Capital to invest $30 million in Valthos, a New York-based biosecurity startup developing software that
The same technology that can write poetry, design proteins, or diagnose disease is now being used to prevent something far darker — AI-assisted biological attacks. To get ahead of that threat, OpenAI has teamed up with Founders Fund and Lux Capital t… [3350 chars]
Source: TechStartups.com | Published: 2025-10-24T15:40:48Z
Credit: TechStartups.com
